AUS
NZ
UK
CA
USA
FRA
GER
ESP
ITA
NLD
PRT
SWE
GRC
IND
POL
BRA
ZAF
RUS
CHN
UAE
Healthcare
Celadon Pharmaceuticals Highlights Recent Progress and Financial Position
August 12, 2024 08:12 PM AEST| By Team Kalkine MediaCeladon Pharmaceuticals Plc (LSE: CEL), a UK-based pharmaceutical firm specializing in cannabis-based medicines, reports that its operations are proceeding according to management expectations. The company has been managing its financial position car...
Hikma Pharmaceuticals Surpasses Expectations with Earnings Report
August 12, 2024 09:00 AM AEST| By Team Kalkine MediaHikma Pharmaceuticals PLC, a key player in the,healthcare sector,, recently released its half-yearly financial results, which exceeded market expectations. The company reported revenues of US$1.6 billion, surpassing forecasts, and achieved statutory...
Assessing Haleon plc's Dividend Prospects Amid Flat Earnings
August 12, 2024 09:00 AM AEST| By Team Kalkine MediaHaleon plc, a notable player in the,healthcare sector,, is approaching its ex-dividend date in just three days, which may be of interest to shareholders and those monitoring dividend payments. The ex-dividend date, which falls on the 15th of August,...
Oncimmune Holdings PLC Secures $1.5 Million Contract
August 09, 2024 06:03 PM AEST| By Team Kalkine MediaOncimmune Holdings PLC (LSE: ONC), a company specializing in autoantibody profiling, has secured a new contract with a leading global pharmaceutical firm. The agreement, valued at no less than $1.5 million, follows a successful pilot project conducte...
How Did MaxCyte Perform in Its Second-Quarter Results?
August 09, 2024 09:00 AM AEST| By Team Kalkine MediaMaxCyte, Inc. an,Healthcare sector,firm has released its second-quarter results, showcasing stronger-than-expected performance. The company's revenue reached US$10 million, surpassing expectations by 31%. Although MaxCyte reported a statutory loss of...
Hikma Pharmaceuticals Reports Increased Profit and Dividend Amid Strategic Acquisitions
August 08, 2024 09:00 PM AEST| By Team Kalkine MediaHikma Pharmaceuticals PLC (LSE: HIK) has reported financial results for the first half of 2024. The company’s pretax profit increased by 43%, reaching £288 million, compared to £202 million in the same period last year. Revenue grew by 10%, totaling...
Assura plc Expands into Private Healthcare with £500 Million Acquisition of UK Hospital Portfolio
August 08, 2024 07:59 PM AEST| By Team Kalkine MediaAssura plc (LSE:AGR), a leading UK healthcare property investor and developer, has announced a major expansion into the private healthcare sector with the acquisition of a fully operational UK private hospital portfolio from Northwest Healthcare Prop...
Faron Pharma Shares Rise After New CMO Appointment
August 07, 2024 11:18 PM AEST| By Team Kalkine MediaFaron Pharmaceuticals Limited, operating in the,healthcare sector,, announced the appointment of Dr. Petri Bono as its new Chief Medical Officer (CMO), effective 15 August.,Faron Pharmaceuticals Limited revealed that Dr. Bono, formerly the CMO at Ter...
Genedrive Shares Drop 10% Following CEO Departure
August 07, 2024 10:49 PM AEST| By Team Kalkine MediaGenedrive PLC, operating in the,Healthcare sector,, saw its shares decline by 10% following the announcement that CEO James Cheek has left the company by mutual agreement. Genedrive, experienced a decrease of 0.3p to 2.8p in early trading.,Dr. Gino M...
Glencore's EBITDA Falls in H1 2024 Results, Driven by Normalized Energy Markets
August 07, 2024 07:42 PM AEST| By Team Kalkine MediaGlencore PLC (LSE:GLEN) reported a mixed set of results for the first half of 2024, reflecting significant shifts in the energy markets. The company's adjusted EBITDA stood at $6.3 billion, down 33% from the same period last year. This decline was ma...
Haleon PLC Appoints New Non-Executive Directors
August 06, 2024 10:11 PM AEST| By Team Kalkine MediaHaleon PLC (LSE: HLN), the consumer healthcare company headquartered in Weybridge, Surrey, has announced the appointment of Alan Stewart and Nancy Avila as non-executive directors, effective September 1. Stewart, previously the Chief Financial Office...
GSK Declares £0.15 Dividend, Increasing Returns for Stakeholders
August 06, 2024 09:55 PM AEST| By Team Kalkine MediaA significant player of,Healthcare Sector,GlaxoSmithKline PLC,has declared a dividend payment of £0.15 per share, scheduled for October 10th. This dividend corresponds to a yield of 3.7%, offering a notable return to stakeholders.,Dividend Coverage a...
Faron Pharmaceuticals Appoints Dr. Petri Bono as New Chief Medical Officer
August 06, 2024 07:48 PM AEST| By Team Kalkine MediaFaron Pharmaceuticals Ltd. (AIM:FARN), a clinical-stage biopharmaceutical company focused on pioneering CLEVER-1 receptor-targeting approaches to enhance anti-tumor immunity in treatment-resistant cancers, has announced the appointment of Dr. Petri B...
.png)
GSK Triumphs in Illinois Court, Jury Finds No Cancer Link to Ranitidine
August 06, 2024 07:17 PM AEST| By Team Kalkine MediaGSK plc (LSE/NYSE:GSK) announced today that a jury in Illinois state court has ruled in its favor in the Joiner case. This decision is a significant victory for the company, reinforcing its stance that ranitidine does not pose a cancer risk.,Scientif...
Why Johnson Matthey’s High P/E Ratio Deserves Closer Watch?
August 05, 2024 10:48 PM AEST| By Team Kalkine MediaJohnson Matthey PLC’s (LSE: JMAT) P/E ratio of 26.6x is notably higher than the UK market average of around 16x. This ratio indicates that investors have expectations for the company's future performance, as a high P/E ratio generally reflects a prem...
IXICO Appoints New CEO, Bram Goorden
August 05, 2024 06:27 PM AEST| By Team Kalkine MediaIXICO plc (AIM:IXI), a leading precision analytics company specializing in neuroscience, is pleased to announce the appointment of Bram Goorden as Chief Executive Officer (CEO), effective from 19 August 2024. Bram will succeed Giulio Cerroni, who is...
_08_02_2023_11_21_17_866226.jpg)
hVIVO to Cancel Euronext Growth Listing to Focus on AIM Market
August 05, 2024 06:23 PM AEST| By Team Kalkine MediahVIVO plc (AIM:HVO), a leading specialist contract research organization (CRO) renowned for its expertise in human challenge clinical trials for infectious and respiratory diseases, has announced its decision to cancel its listing on Euronext Growth....
Haleon Announces Increase in 1H 2024 Interim Dividend
August 01, 2024 07:42 PM AEST| By Team Kalkine MediaHaleon plc (LSE/NYSE:,HLN,) has announced its half-year results for the period ending 31 December 2024, along with a significant increase in its interim dividend. Consistent with the company's previous guidance to grow the dividend in line with earni...
Smith+Nephew Reports 1H and 2Q Results, Maintains 2024 Guidance
August 01, 2024 07:39 PM AEST| By Team Kalkine MediaSmith+Nephew (LSE: SN, NYSE:,SNN,), a global medical technology company, reported its financial results for the second quarter and the first half ended June 29, 2024. The company demonstrated robust growth across key financial metrics, underscoring i...
Croda International Share Price Falls 62% Today. Here’s Why.
August 01, 2024 03:35 AM AEST| By Team Kalkine MediaCroda International (,LSE:CRDA,), a chemicals company renowned for its high-quality products used in various industries, has seen its share price decline by 62% from its 2021 highs. The latest trading update initially painted a bleak picture, causing...
AI on the Rise: A Look at Top AI Companies and Their Stocks